Skip to main content
Log in

Trilobatin Ameliorates Inflammatory Response by Regulating the miR375-Mediated Fatty Acid Binding Protein 4 Expression in Adipocytes

  • Original Article
  • Published:
Revista Brasileira de Farmacognosia Aims and scope Submit manuscript

Abstract

Fatty acid binding protein 4 is predominantly expressed in adipose tissue and functions as an important mediator of inflammation. However, small molecules that regulate its expression in adipocytes have not been adequately characterized. In this study, we found that trilobatin dose-dependently attenuates the mRNA expression and protein levels of fatty acid binding protein 4 induced by lipopolysaccharide in the differentiated 3T3-L1 adipocytes. Meanwhile, trilobatin also reduced the mRNA and protein levels of fatty acid binding protein 4 in the epididymal white adipose tissue and the contents of pro-inflammatory cytokines, including tumor necrosis factor α and interleukin-6 in the serum of obese-hyperglycemic mice. In addition, trilobatin protected against the decrease of microRNA precursors, including premiR-375, premiR-338, and premiR-129, but only miR-375 inhibitor prohibited the role of trilobatin on the expression of fatty acid binding protein 4, suggesting that miR-375 might be involved in trilobatin regulating this protein expression in LPS-treated differentiated 3T3-L1 adipocytes. All these findings suggest that trilobatin might be a promising compound for the management of obesity due to its anti-inflammatory activity by suppressing the expression of fatty acid binding protein 4 in adipocytes.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

The data and materials of the current study are available from the corresponding author on reasonable request.

References

Download references

Funding

This work was supported by the Scientific and Technological Research Program of Chongqing Municipal Education Commission (Grant, KJZD-K202101102, KJQN201901139) and Chongqing Science & Technology Bureau (cstc2019jcyj-msxmX0427).

Author information

Authors and Affiliations

Authors

Contributions

LXG and WYC performed research and analyzed results. YF performed statistical analysis. LJH, YF, and YL wrote and edited the manuscript. LJH and YL designed the project and contributed the research questions. All authors have read the final version of this paper and approved its publication.

Corresponding author

Correspondence to Jianhui Liu.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 395 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Wu, Y., Jiang, X. et al. Trilobatin Ameliorates Inflammatory Response by Regulating the miR375-Mediated Fatty Acid Binding Protein 4 Expression in Adipocytes. Rev. Bras. Farmacogn. 33, 214–221 (2023). https://doi.org/10.1007/s43450-022-00356-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43450-022-00356-5

Keywords

Navigation